"Azathioprine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
| Descriptor ID |
D001379
|
| MeSH Number(s) |
D02.886.759.111 D03.633.100.759.534.090 D13.570.900.111
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Azathioprine".
Below are MeSH descriptors whose meaning is more specific than "Azathioprine".
This graph shows the total number of publications written about "Azathioprine" by people in this website by year, and whether "Azathioprine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2002 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 2 | 1 | 3 |
| 2017 | 11 | 14 | 25 |
| 2018 | 12 | 8 | 20 |
| 2019 | 4 | 5 | 9 |
| 2020 | 1 | 3 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Azathioprine" by people in Profiles.
-
Autoimmune hepatitis triggered by COVID-19: A report of two cases. Liver Int. 2021 10; 41(10):2527-2528.
-
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J Autoimmun. 2021 09; 123:102710.
-
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. CNS Drugs. 2021 03; 35(3):317-330.
-
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with? Reumatismo. 2020 Nov 19; 72(3):173-177.
-
COVID-19 and IBD drugs: should we change anything at the moment? Gut. 2021 04; 70(4):632-634.
-
Effect of IBD medications on COVID-19 outcomes: results from an international registry. Gut. 2021 04; 70(4):725-732.
-
COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence? Mult Scler. 2021 05; 27(6):973-976.
-
Impact of Anti-Tumor Necrosis Factor and Thiopurine Medications on the Development of COVID-19 in Patients With Inflammatory Bowel Disease: A Nationwide Veterans Administration Cohort Study. Gastroenterology. 2020 10; 159(4):1545-1546.e1.
-
Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19. Clin Dermatol. 2020 Nov-Dec; 38(6):775-780.
-
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine. Ann Rheum Dis. 2020 10; 79(10):1382-1383.